Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Branigan, R. Turner, A. Stojmirovic, M. Loza, A. Delvecchio, S. Marciniak, N. Peffer, P. Silkoff, R. Dobrin, F. Baribaud (Spring House, Charlottesville, United States Of America). A peripheral HRV-16-driven fingerprint is enriched in severe asthma patients in absence of an active exacerbation. Eur Respir J 2014; 44: Suppl. 58, 241

Member's Comments

No comment yet.

Related content which might interest you: Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Etiological structure from sputum of patients with exacerbation of COPD Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014 Dupilumab reduces severe exacerbations in periostin-high and periostin-low asthma patients Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives Year: 2016 Asthma patients hospitalized with influenza lack mucosal and systemic type 2 inflammation Source: International Congress 2016 – Molecular immunology of the lung Year: 2016 Treatment failure of hospitalized patients with COPD exacerbation using systemic corticosteroids plus antibiotics: Role of early inflammatory predictors Source: International Congress 2014 – Asthma and COPD management Year: 2014 LATE-BREAKING ABSTRACT: The Guangzhou COPD exacerbation study: relationship of exacerbations with viral infections and soluble biomarkers Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Analysis of the level of cytokines in blood serum and condensate in children with bronchopulmonary pathology Source: International Congress 2014 – Respiratory infections in children Year: 2014 Development of a human COPD model-on-a-chip to mimic disease exacerbation (a small airway-on-a-chip model) Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Functional and immunological abnormalities in patients with severe asthma Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013 Sesonal variations of severe asthma exacerbations in the US Source: International Congress 2014 – Risk factors for respiratory disease Year: 2014 Outcomes of immunotherapy of patients with COPD Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Prevention of the recurrent acute respiratory viral infections and virus-induced exacerbation of bronchial asthma in children Source: Annual Congress 2013 –Preschool wheeze Year: 2013 Identification of nasal virus infection in patients with COPD exacerbations Source: International Congress 2014 – COPD: points to ponder Year: 2014 Immunoglobulin G subclass deficiency in adult patients with chronic obstructive lung diseases Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections Year: 2014 Immunology indices in severe bronchial asthma with different levels of disease control in children Source: Annual Congress 2013 –Asthma Year: 2013 Cells biomarkers of bronchial brush-biopsies at COPD exacerbation Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system Year: 2013 Airway MUC2 is decreased in patients with severe COPD and bacterial colonization Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections Year: 2014 Clustering of multiplex-qPCR data for the detection of respiratory viruses in acute bronchiolitis Source: International Congress 2014 – More paediatric asthma Year: 2014 Relationship between procacitonin and C-reactive protein and sputum culture results in patients with acute excecerbation of COPD Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014 Differences in systemic immune function contribute to exacerbation susceptibility in COPD patients Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015